rs761962858

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001145252.3(CFP):​c.236G>A​(p.Arg79Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000553 in 1,206,119 control chromosomes in the GnomAD database, including 4 homozygotes. There are 354 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.00021 ( 0 hom., 10 hem., cov: 23)
Exomes 𝑓: 0.00059 ( 4 hom. 344 hem. )

Consequence

CFP
NM_001145252.3 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.25

Publications

2 publications found
Variant links:
Genes affected
CFP (HGNC:8864): (complement factor properdin) This gene encodes a plasma glycoprotein that positively regulates the alternative complement pathway of the innate immune system. This protein binds to many microbial surfaces and apoptotic cells and stabilizes the C3- and C5-convertase enzyme complexes in a feedback loop that ultimately leads to formation of the membrane attack complex and lysis of the target cell. Mutations in this gene result in two forms of properdin deficiency, which results in high susceptibility to meningococcal infections. Multiple alternatively spliced variants, encoding the same protein, have been identified.[provided by RefSeq, Feb 2009]
CFP Gene-Disease associations (from GenCC):
  • properdin deficiency, X-linked
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0075173676).
BP6
Variant X-47628269-C-T is Benign according to our data. Variant chrX-47628269-C-T is described in ClinVar as Benign. ClinVar VariationId is 235395.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000206 (23/111864) while in subpopulation SAS AF = 0.00782 (21/2687). AF 95% confidence interval is 0.00524. There are 0 homozygotes in GnomAd4. There are 10 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 10 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CFPNM_001145252.3 linkc.236G>A p.Arg79Gln missense_variant Exon 3 of 9 ENST00000396992.8 NP_001138724.1 P27918A0A0S2Z4I5
CFPNM_002621.2 linkc.236G>A p.Arg79Gln missense_variant Exon 4 of 10 NP_002612.1 P27918A0A0S2Z4I5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CFPENST00000396992.8 linkc.236G>A p.Arg79Gln missense_variant Exon 3 of 9 1 NM_001145252.3 ENSP00000380189.3 P27918

Frequencies

GnomAD3 genomes
AF:
0.000206
AC:
23
AN:
111812
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000281
Gnomad SAS
AF:
0.00779
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00114
AC:
195
AN:
170702
AF XY:
0.00161
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000152
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000148
Gnomad OTH exome
AF:
0.00117
GnomAD4 exome
AF:
0.000589
AC:
644
AN:
1094255
Hom.:
4
Cov.:
31
AF XY:
0.000955
AC XY:
344
AN XY:
360023
show subpopulations
African (AFR)
AF:
0.0000380
AC:
1
AN:
26329
American (AMR)
AF:
0.00
AC:
0
AN:
34751
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19300
East Asian (EAS)
AF:
0.0000998
AC:
3
AN:
30050
South Asian (SAS)
AF:
0.00983
AC:
526
AN:
53506
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40261
Middle Eastern (MID)
AF:
0.000726
AC:
3
AN:
4132
European-Non Finnish (NFE)
AF:
0.0000929
AC:
78
AN:
839989
Other (OTH)
AF:
0.000718
AC:
33
AN:
45937
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
19
38
58
77
96
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000206
AC:
23
AN:
111864
Hom.:
0
Cov.:
23
AF XY:
0.000294
AC XY:
10
AN XY:
34036
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30752
American (AMR)
AF:
0.00
AC:
0
AN:
10619
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2643
East Asian (EAS)
AF:
0.000282
AC:
1
AN:
3551
South Asian (SAS)
AF:
0.00782
AC:
21
AN:
2687
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6064
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53117
Other (OTH)
AF:
0.00
AC:
0
AN:
1526
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000811
Hom.:
0
Bravo
AF:
0.0000869
ExAC
AF:
0.00145
AC:
176

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 30, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CFP-related disorder Benign:1
Jun 11, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.76
T
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.0080
DANN
Benign
0.75
DEOGEN2
Benign
0.13
T;T;T
FATHMM_MKL
Benign
0.0059
N
LIST_S2
Benign
0.57
.;T;T
MetaRNN
Benign
0.0075
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.42
N;N;.
PhyloP100
-2.2
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-0.38
N;N;N
REVEL
Benign
0.027
Sift
Benign
0.53
T;T;T
Sift4G
Benign
0.55
T;T;T
Polyphen
0.0040
B;B;.
Vest4
0.062
MutPred
0.50
Loss of MoRF binding (P = 0.0454);Loss of MoRF binding (P = 0.0454);Loss of MoRF binding (P = 0.0454);
MVP
0.10
MPC
0.74
ClinPred
0.0043
T
GERP RS
-5.6
Varity_R
0.091
gMVP
0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs761962858; hg19: chrX-47487668; COSMIC: COSV55949624; COSMIC: COSV55949624; API